Literature DB >> 25761495

Who should undergo a colonoscopy among patients with incidental colon uptake on PET-CT?

Soo-Young Na1, Kyung-Jo Kim, Seungbong Han, Soyoung Jin, Jae Seung Kim, Dong-Hoon Yang, Kee Wook Jung, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim.   

Abstract

OBJECTIVES: To investigate the optimal cut-off of the maximum standard uptake value (SUVmax) for the detection of colorectal neoplasms and to suggest those for whom further colonoscopy is recommended among patients with incidental colonic uptake on positron emission tomography-computed tomography (PET-CT).
MATERIALS AND METHODS: In 306 patients who underwent colonoscopy within 3 months of receiving PET-CT between January and December 2009, measurements of the per-patient and per-lesion diagnostic performance of PET-CT for the detection of colonic neoplasms were obtained. Receiver operating characteristic (ROC) analysis was used to identify the SUVmax that provided a high probability of diagnosing malignancy and high-grade dysplasia.
RESULTS: The per-patient and per-lesion PET-CT detection sensitivities for malignancies were 93.3% (28/30; 95% confidence interval (CI) 76.5% to 98.9%) and 93.5% (29/31, 95% CI 77.2% to 98.9%), respectively; the sensitivities for high-grade dysplasia were both 90.0% (9/10; 95% CI 54.1% to 99.5%). As a criterion to specifically detect both malignancy and high-grade dysplasia on focal uptake, a SUVmax greater than 2.5 yielded a 92.3% per-lesion sensitivity and a 42.9% per-lesion positive predictive value (PPV). In the ROC curve analysis, a cut-off value of SUVmax = 5.8 was established, at which the sensitivity, PPV and positive likelihood ratio for diagnosing malignancy and high-grade dysplasia were 71.8% (28/39; 95% CI 54.9% to 84.5%), 84.8% (28/33; 95% CI 67.3% to 94.3%) and 6.9, respectively.
CONCLUSION: The optimal cut-off value to identify a malignancy or high-grade dysplasia was SUVmax = 5.8. However, to avoid missing a malignancy or high-grade dysplasia, a colonoscopy should be performed above a SUVmax = 2.5.

Entities:  

Keywords:  PET-CT; colonoscopy; colorectal neoplasm; maximum standard uptake value

Mesh:

Year:  2015        PMID: 25761495     DOI: 10.3109/00365521.2014.992363

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: a systematic review.

Authors:  S J Kousgaard; O Thorlacius-Ussing
Journal:  Tech Coloproctol       Date:  2017-06-15       Impact factor: 3.781

2.  Incidental colorectal focal 18 F-FDG uptake: a novel indication for colonoscopy.

Authors:  Eugénie Rigault; Laurence Lenoir; Guillaume Bouguen; Mael Pagenault; Astrid Lièvre; Etienne Garin; Laurent Siproudhis; Jean-François Bretagne
Journal:  Endosc Int Open       Date:  2017-09-13

3.  Incidental detection of colorectal lesions on 18 F-FDG-PET/CT is associated with high proportion of malignancy: A study in 549 patients.

Authors:  Sabrina Just Kousgaard; Michael Gade; Lars Jelstrup Petersen; Ole Thorlacius-Ussing
Journal:  Endosc Int Open       Date:  2020-11-17

4.  Combined SUVmax and localized colonic wall thickening parameters to identify high-risk lesions from incidental focal colorectal 18F-FDG uptake foci.

Authors:  Wenmin Xu; Hansen Li; Ziqian Guo; Linqi Zhang; Rusen Zhang; Long Zhang
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

5.  Focal colorectal uptake in (18)FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting.

Authors:  Wolfgang Luboldt; Baerbel Wiedemann; Sebastian Fischer; Boris Bodelle; Hans Joachim Luboldt; Frank Grünwald; Thomas J Vogl
Journal:  Eur J Med Res       Date:  2016-01-09       Impact factor: 2.175

6.  Efficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer.

Authors:  Daisuke Hojo; Toshiaki Tanaka; Miwako Takahashi; Koji Murono; Shigenobu Emoto; Manabu Kaneko; Kazuhito Sasaki; Kensuke Otani; Takeshi Nishikawa; Keisuke Hata; Kazushige Kawai; Toshimitsu Momose; Hiroaki Nozawa
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.